SLAM
SANA icon

Swiss Life Asset Management’s Sana Biotechnology SANA Stock Holding History

Swiss Life Asset Management’s Portfolio SANA Stock Details SANA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$50.2K Buy
14,391
+1,555
+12% +$5.01K ﹤0.01% 1628
2026
Q1 		$37K Buy
+12,836
New +$50.6K ﹤0.01% 1493

Other funds holding SANA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
AI
Alphabet Inc Mountain View, California $99.1B AUM 124.46% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
Corient Private Wealth
Corient Private Wealth Miami, Florida $78.6B AUM 28.08% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return
Swiss National Bank
Swiss National Bank Zurich, Switzerland $191B AUM 45.21% 1-Year Est. Return

Swiss Life Asset Management's SANA Position: Q2 2026 in Review

Swiss Life Asset Management increased its Sana Biotechnology (SANA) stake by 12% in Q2 2026, buying an estimated $5.01K and bringing the position to 14,391 shares worth $50.2K. The position accounts for ﹤0.01% of the portfolio, ranked #1628.

Swiss Life Asset Management first reported a position in SANA in Q1 2026 and has held it in 2 quarters since. 119 funds tracked by Wall St. Rank hold SANA as of Q2 2026.

  • Swiss Life Asset Management held 14,391 shares of Sana Biotechnology worth $50.2K as of Q2 2026.
  • Swiss Life Asset Management bought 1,555 Sana Biotechnology shares in Q2 2026, an estimated $5.01K.
  • Sana Biotechnology made up ﹤0.01% of Swiss Life Asset Management's portfolio in Q2 2026, its #1628 holding.
  • Swiss Life Asset Management first reported a position in Sana Biotechnology in Q1 2026 and has held it in 2 quarters since.
  • 119 funds tracked by Wall St. Rank held Sana Biotechnology as of Q2 2026.

Based on Swiss Life Asset Management's 13F filing for Q2 2026, filed 29 Jul 2026.